UBS AM
VERA icon

UBS AM’s Vera Therapeutics VERA Stock Holding History

UBS AM’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.96M Sell
197,769
-5,184
-3% -$223K ﹤0.01% 1328
2025
Q4 		$10.3M Buy
202,953
+120,671
+147% +$4.29M ﹤0.01% 1119
2025
Q3 		$2.39M Sell
82,282
-70,816
-46% -$1.64M ﹤0.01% 1678
2025
Q2 		$3.61M Buy
153,098
+55,085
+56% +$1.24M ﹤0.01% 1861
2025
Q1 		$2.35M Buy
98,013
+17,907
+22% +$575K ﹤0.01% 1914
2024
Q4 		$3.39M Buy
80,106
+18,532
+30% +$821K ﹤0.01% 1792
2024
Q3 		$2.72M Buy
61,574
+6,494
+12% +$246K ﹤0.01% 1880
2024
Q2 		$1.99M Buy
55,080
+23,303
+73% +$924K ﹤0.01% 2002
2024
Q1 		$1.37M Buy
31,777
+10,460
+49% +$373K ﹤0.01% 1858
2023
Q4 		$328K Buy
+21,317
New +$271K ﹤0.01% 2409

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return